Home/Neuronetics/Keith J. Sullivan

KJ

Keith J. Sullivan

President and Chief Executive Officer

Therapeutic Areas

Psychiatry Neuroscience

Neuronetics Pipeline

Drug	Indication	Phase
NeuroStar Advanced Therapy	Major Depressive Disorder (MDD)	FDA Cleared
NeuroStar System & Software	Platform Enhancement	R&D

Leadership Team at Neuronetics

Stephen Furlong

Chief Financial Officer

Dr. Geoffrey C. Dunbar

Senior Vice President of Clinical and Regulatory Affairs

Cory J. Anderson

Chief Commercial Officer

View full Neuronetics profile